Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOLYTIC T-LYMPHOCYTES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 605 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Max, N; Keilholz, U
      Minimal residual disease in melanoma

      SEMINARS IN SURGICAL ONCOLOGY
    2. Riley, JP; Rosenberg, SA; Parkhurst, MR
      Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase

      JOURNAL OF IMMUNOTHERAPY
    3. Lau, R; Wang, F; Jeffery, G; Marty, V; Kuniyoshi, J; Bade, E; Ryback, ME; Weber, J
      Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    4. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    5. Smith, ES; Mandokhot, A; Evans, EE; Mueller, L; Borrello, MA; Sahasrabudhe, DM; Zauderer, M
      Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens

      NATURE MEDICINE
    6. Wolfers, J; Lozier, A; Raposo, G; Regnault, A; Thery, C; Masurier, C; Flament, C; Pouzieux, S; Faure, F; Tursz, T; Angevin, E; Amigorena, S; Zitvogel, L
      Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming

      NATURE MEDICINE
    7. Sadanaga, N; Nagashima, H; Mashino, K; Tahara, K; Yamaguchi, H; Ohta, M; Fujie, T; Tanaka, F; Inoue, H; Takesako, K; Akiyoshi, T; Mori, M
      Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas

      CLINICAL CANCER RESEARCH
    8. Nishiyama, T; Tachibana, M; Horiguchi, Y; Nakamura, K; Ikeda, Y; Takesako, K; Murai, M
      Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide

      CLINICAL CANCER RESEARCH
    9. Stinchcombe, JC; Bossi, G; Booth, S; Griffiths, GM
      The immunological synapse of CTL contains a secretory domain and membrane bridges

      IMMUNITY
    10. Jungbluth, AA; King, R; Fisher, DE; Iversen, K; Coplan, K; Kolb, D; Williamson, B; Chen, YT; Stockert, E; Old, LJ; Busam, KJ
      Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    11. Dunussi-Joannopoulos, K; Leonard, JP
      Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia

      LEUKEMIA & LYMPHOMA
    12. Weber, JS; Aparicio, A
      Novel immunologic approaches to the management of malignant melanoma

      CURRENT OPINION IN ONCOLOGY
    13. Jager, D; Jager, E; Knuth, A
      Targets for immunotherapy in breast cancer

      BREAST
    14. Jager, E; Jager, D; Knuth, A
      Vaccines in breast cancer

      BREAST
    15. Zendman, AJW; de Wit, NJW; van Kraats, AA; Weidle, UH; Ruiter, DJ; van Muijen, GNP
      Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma

      MELANOMA RESEARCH
    16. Kulik, J; Nowecki, ZI; Rutkowski, P; Ruka, W; Rochowska, M; Skurzak, H; Siedlecki, JA
      Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay

      MELANOMA RESEARCH
    17. Van den Eynde, BJ; Morel, S
      Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

      CURRENT OPINION IN IMMUNOLOGY
    18. Soloski, MJ
      Recognition of tumor cells by the innate immune system

      CURRENT OPINION IN IMMUNOLOGY
    19. Wang, TT; Fan, LQ; Watanabe, Y; McNeill, P; Fanger, GR; Persing, DH; Reed, SG
      L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma

      ONCOGENE
    20. Kavalar, R; Sarcevic, B; Spagnoli, GC; Separovic, V; Samija, M; Terracciano, L; Heberer, M; Juretic, A
      Expression of MAGE tumour-associated antigens is inversely correlated withtumour differentiation in invasive ductal breast cancers: an immunohistochemical study

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    21. Smyth, MJ; Kelly, JM; Sutton, VR; Davis, JE; Browne, KA; Sayers, TJ; Trapani, JA
      Unlocking the secrets of cytotoxic granule proteins

      JOURNAL OF LEUKOCYTE BIOLOGY
    22. Lee, P; Wang, F; Kuniyoshi, J; Rubio, V; Stuges, T; Groshen, S; Gee, C; Lau, R; Jeffery, G; Margolin, K; Marty, V; Weber, J
      Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    23. Raulet, DH; Vance, RE; McMahon, CW
      Regulation of the natural killer cell receptor repertoire

      ANNUAL REVIEW OF IMMUNOLOGY
    24. Kawano, Y; Sasaki, M; Nakahira, K; Yoshimine, T; Shimizu, K; Wada, H; Ikenaka, K
      Structural characterization and chromosomal localization of the MAGE-E1 gene

      GENE
    25. Mazzocchi, A; Melani, C; Rivoltini, L; Castelli, C; Del Vecchio, M; Lombardo, C; Colombo, MP; Parmiani, G
      Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    26. Renkvist, N; Castelli, C; Robbins, PF; Parmiani, G
      A listing of human tumor antigens recognized by T cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    27. Srivastava, PK; Amato, RJ
      Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents

      VACCINE
    28. Moingeon, P
      Cancer vaccines

      VACCINE
    29. Chersi, A; Garzillo, C; Butler, RH; Tanigaki, N
      Allele- and temperature-dependency of in vitro HLA class I assembly

      HUMAN IMMUNOLOGY
    30. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
      Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line

      HUMAN IMMUNOLOGY
    31. Ma, ZY; Khatlani, TS; Li, L; Sasaki, K; Okuda, M; Inokuma, H; Onishi, T
      Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    32. Haverson, K; Saalmuller, A; Alvarez, B; Alonso, F; Bailey, M; Bianchi, ATJ; Boersma, WJA; Chen, Z; Davis, WC; Dominguez, J; Engelhardt, H; Ezquerra, A; Grosmaire, LS; Hamilton, MJ; Hollemweguer, E; Huang, CA; Khanna, KV; Kuebart, G; Lackovic, G; Ledbetter, JA; Lee, R; Llanes, D; Lunney, JK; McCullough, KC; Molitor, T; Nielsen, J; Niewold, TA; Pescovitz, MD; de la Lastra, JP; Rehakova, Z; Salmon, H; Schnitzlein, WM; Seebach, J; Simon, A; Sinkora, J; Sinkora, M; Stokes, CR; Summerfield, A; Sver, L; Thacker, E; Valpotic, I; Yang, H; Zuckermann, FA; Zwart, R
      Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    33. Ahmad, R; Sindhu, STAK; Tran, P; Toma, E; Morisset, R; Menezes, J; Ahmad, A
      Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients

      JOURNAL OF MEDICAL VIROLOGY
    34. Cheung, IY; Cheung, NKV
      Detection of microscopic disease: Comparing histology, immunocytology, andRT-PCR of tyrosine hydroxylase, GAGE, and MAGE

      MEDICAL AND PEDIATRIC ONCOLOGY
    35. Safa, MM; Foon, KA
      Adjuvant immunotherapy for melanoma, and colorectal cancers

      SEMINARS IN ONCOLOGY
    36. Gravekamp, C
      Tailoring cancer vaccines to the elderly: the importance of suitable mousemodels

      MECHANISMS OF AGEING AND DEVELOPMENT
    37. Robertson, H; Wong, WK; Talbot, D; Burt, AD; Kirby, JA
      Tubulitis after renal transplantation: Demonstration of an association between CD103+T cells, transforming growth factor beta(1) expression and rejection grade

      TRANSPLANTATION
    38. Jager, D; Jagar, E; Knuth, A
      Vaccination for malignant melanoma: Recent developments

      ONCOLOGY
    39. Rosenberg, SA
      Progress in human tumour immunology and immunotherapy

      NATURE
    40. Ono, T; Kurashige, T; Harada, N; Noguchi, Y; Saika, T; Niikawa, N; Aoe, M; Nakamura, S; Higashi, T; Hiraki, A; Wada, H; Kumon, H; Old, LJ; Nakayama, E
      Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    41. Goydos, JS; Patel, M; Shih, WC
      NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma

      JOURNAL OF SURGICAL RESEARCH
    42. Mullins, DW; Bullock, TNJ; Colella, TA; Robila, VV; Engelhard, VH
      Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice

      JOURNAL OF IMMUNOLOGY
    43. Salio, M; Shepherd, D; Dunbar, PR; Palmowski, M; Murphy, K; Wu, LJ; Cerundolo, V
      Mature dendritic cells prime functionally superior melan-A-specific CD8(+)lymphocytes as compared with nonprofessional APC

      JOURNAL OF IMMUNOLOGY
    44. Roberts, AI; Lee, L; Schwarz, E; Groh, V; Spies, T; Ebert, EC; Jabri, B
      Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

      JOURNAL OF IMMUNOLOGY
    45. Beck-Engeser, GB; Monach, PA; Mumberg, D; Yang, F; Wanderling, S; Schreiber, K; Espinosa, R; Le Beau, MM; Meredith, SC; Schreiber, H
      Point mutation in essential genes with loss or mutation of the second allele: Relevance to the retention of tumor-specific antigens

      JOURNAL OF EXPERIMENTAL MEDICINE
    46. Jager, D; Jager, E; Knuth, A
      Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

      JOURNAL OF CLINICAL PATHOLOGY
    47. Berset, M; Cerottini, JP; Guggisberg, D; Romero, P; Burri, F; Rimoldi, D; Panizzon, RG
      Expression of Melan-A/MART-1 antigen as a prognostic reactor in primary cutaneous melanoma

      INTERNATIONAL JOURNAL OF CANCER
    48. Dalerba, P; Frascella, E; Macino, B; Mandruzzato, S; Zambon, A; Rosolen, A; Carli, M; Ninfo, V; Zanovello, P
      MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas

      INTERNATIONAL JOURNAL OF CANCER
    49. Jungbluth, AA; Chen, YT; Stockert, E; Busam, KJ; Kolb, D; Iversen, K; Coplan, K; Williamson, B; Altorki, N; Old, LJ
      Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

      INTERNATIONAL JOURNAL OF CANCER
    50. Gasparollo, A; Coral, S; Ciullo, M; Prisco, A; Cattarossi, I; Sigalotti, L; Altomonte, M; Guardiola, J; Maio, M
      Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma

      INTERNATIONAL JOURNAL OF CANCER
    51. Smith, C; Cerundolo, V
      Immunotherapy of melanoma

      IMMUNOLOGY
    52. Benlalam, H; Labarriere, N; Linard, B; Derre, L; Diez, E; Pandolfino, MC; Bonneville, M; Jotereau, F
      Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

      EUROPEAN JOURNAL OF IMMUNOLOGY
    53. Chaux, P; Lethe, B; Van Snick, J; Corthals, J; Schultz, ES; Cambiaso, CL; Boon, T; van der Bruggen, P
      A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    54. Chiplunkar, SV
      The immune system and cancer

      CURRENT SCIENCE
    55. Jager, D; Stockert, E; Gure, AO; Scanlan, MJ; Karbach, J; Jager, E; Knuth, A; Old, LJ; Chen, YT
      Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library

      CANCER RESEARCH
    56. Hanada, K; Perry-Lalley, DM; Ohnmacht, GA; Bettinotti, MP; Yang, JC
      Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas

      CANCER RESEARCH
    57. Kurashige, T; Noguchi, Y; Saika, T; Ono, T; Nagata, Y; Jungbluth, A; Ritter, G; Chen, YT; Stockert, E; Tsushima, T; Kumon, H; Old, LJ; Nakayama, E
      NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade

      CANCER RESEARCH
    58. Lo Piccolo, MS; Cheung, NKV; Cheung, IY
      GD2 synthase - A new molecular marker for detecting neuroblastoma

      CANCER
    59. Aubry, F; Satie, AP; Rioux-Leclercq, N; Rajpert-De Meyts, E; Spagnoli, GC; Chomez, P; De Backer, O; Jegou, B; Samson, M
      MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors

      CANCER
    60. Zambon, A; Mandruzzato, S; Parenti, A; Macino, B; Dalerba, P; Ruol, A; Merigliano, S; Zaninotto, G; Zanovello, P
      MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia

      CANCER
    61. Chouaib, S; Echchakir, H; Angevin, E; Guerra, N; Kosmatopoulos, K; Caignard, A; Lim, A; Baron, V; Ferradini, L; Mami-Chouaib, F
      Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring

      BULLETIN DU CANCER
    62. Armstrong, AC; Hawkins, RE
      Vaccines in oncology: background and clinical potential

      BRITISH JOURNAL OF RADIOLOGY
    63. Mashino, K; Sadanaga, N; Tanaka, F; Yamaguchi, H; Nagashima, H; Inoue, H; Sugimachi, K; Mori, M
      Expression of multiple cancer-testis antigen genes in gastrointestinal andbreast carcinomas

      BRITISH JOURNAL OF CANCER
    64. Harig, S; Witzens, M; Krackhardt, AM; Trojan, A; Barrett, P; Broderick, R; Zauls, AJ; Gribben, JG
      Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues

      BLOOD
    65. Westbrook, VA; Diekman, AB; Naaby-Hansen, S; Coonrod, SA; Klotz, KL; Thomas, TS; Norton, EJ; Flickinger, CJ; Herr, JC
      Differential nuclear localization of the cancer/testis-associated protein,SPAN-X/CTp11, in transfected cells and in 50% of human spermatozoa

      BIOLOGY OF REPRODUCTION
    66. Mosse, CA; Hsu, W; Engelhard, VH
      Tyrosinase degradation via two pathways during reverse translocation to the cytosol

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    67. Cao, JN; Gao, TW; Stanbridge, EJ; Irie, R
      RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    68. Jager, E; Jager, D; Knuth, A
      Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    69. Rosenberg, SA
      Identification of cancer antigens: Impact on development of cancer immunotherapies

      CANCER JOURNAL
    70. Rosenberg, SA
      The identification of cancer antigens: Impact on the development of cancervaccines

      CANCER JOURNAL
    71. Scheibenbogen, C; Schmittel, A; Keilholz, U; Allgauer, T; Hofmann, U; Max, R; Thiel, E; Schadendorf, D
      Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    72. Pietersz, GA; Apostolopoulos, V; McKenzie, IFC
      Generation of cellular immune responses to antigenic tumor peptides

      CELLULAR AND MOLECULAR LIFE SCIENCES
    73. Hicks, MJ; Flaitz, CM
      Oral mucosal melanoma: epidemiology and pathobiology

      ORAL ONCOLOGY
    74. Jones, LA; Salgaller, ML
      Immunologic approaches to antigen discovery for cancer vaccines

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    75. Frost, P; Bonavida, B
      Circumvention of tumor cell escape following specific immunotherapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    76. Rosenberg, SA
      Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    77. Sahin, U; Koslowski, M; Tureci, O; Eberle, T; Zwick, C; Romeike, B; Moringlane, JR; Schwechheimer, K; Feiden, W; Pfreundschuh, M
      Expression of cancer testis genes in human brain tumors

      CLINICAL CANCER RESEARCH
    78. Morel, S; Levy, F; Burlet-Schiltz, O; Brasseur, F; Probst-Kepper, M; Peitrequin, AL; Monsarrat, B; Van Velthoven, R; Cerottini, JC; Boon, T; Gairin, JE; Van den Eynde, BJ
      Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

      IMMUNITY
    79. Asai, T; Storkus, WJ; Whiteside, TL
      Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    80. Robinson, C; Callow, M; Stevenson, S; Scott, B; Robinson, BWS; Lake, RA
      Serologic responses in patients with malignant mesothelioma - Evidence forboth public and private specificities

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    81. Walsh, P; Gouzalez, R; Dow, S; Elmslie, R; Potter, T; Glode, LM
      A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma

      HUMAN GENE THERAPY
    82. Brenner, MK; Heslop, H; Krance, R; Horowitz, M; Strother, D; Nuchtern, J; Grilley, B; Martingano, E; Cooper, K
      Clinical protocol - Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

      HUMAN GENE THERAPY
    83. Brinckerhoff, LH; Thompson, LW; Slingluff, GL
      Melanoma vaccines

      CURRENT OPINION IN ONCOLOGY
    84. Plate, JMD; Harris, JE
      Immune cell functions in pancreatic cancer

      CRITICAL REVIEWS IN IMMUNOLOGY
    85. Chen, Q; Jackson, H; Cebon, J; Gibbs, P; Davis, ID; Trapani, JA
      A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A(27-35) and Melan-A(26-35)

      MELANOMA RESEARCH
    86. Edelson, BT; Unanue, ER
      Immunity to Listeria infection

      CURRENT OPINION IN IMMUNOLOGY
    87. Renner, C; Trumper, L; Pfreundschuh, M
      Tumour vaccines: a new immunotherapeutic approach in oncology

      ANNALS OF HEMATOLOGY
    88. Clotman, F; De Backer, O; De Plaen, E; Boon, T; Picard, J
      Cell- and stage-specific expression of Mage genes during mouse spermatogenesis

      MAMMALIAN GENOME
    89. Niiya, F; Nishizaka, S; Matsunaga, K; Koufuji, K; Mori, M; Katai, H; Yamana, H; Itoh, K
      Expression of SART3 tumor-rejection antigen in gastric cancers

      JAPANESE JOURNAL OF CANCER RESEARCH
    90. Busam, KJ; Iversen, K; Berwick, M; Spagnoli, GC; Old, LJ; Jungbluth, AA
      Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters

      MODERN PATHOLOGY
    91. Heisele, O; Ferdats, A; Engele, L
      Melanoma associated antigens as additional markers of tumor progression

      JOURNAL OF TUMOR MARKER ONCOLOGY
    92. Jager, E; Jager, D; Knuth, A
      Peptide vaccination in clinical oncology

      ONKOLOGIE
    93. Chen, HS; Cai, SL; Wang, Y; Zhao, HT; Peng, J; Pang, XW; Zhu, JY; Cong, Y; Rui, J; Leng, XS; Du, RY; Wang, Y; Vaughan, H; Cebon, J; Burgess, AW; Chen, WF
      Expression of the MAGE-1 gene in human hepatocellular carcinomas

      CHINESE MEDICAL JOURNAL
    94. Pfreundschuh, M
      Exploitation of the B cell repertoire for the identification of human tumor antigens

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    95. Knuth, A; Jager, D; Jager, E
      Cancer immunotherapy in clinical oncology

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    96. Jungbluth, AA; Iversen, K; Coplan, K; Kolb, D; Stockert, E; Chen, YT; Old, LJ; Busam, K
      T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues

      PATHOLOGY RESEARCH AND PRACTICE
    97. Ishigami, S; Natsugoe, S; Tokuda, K; Nakajo, A; Xiangming, C; Iwashige, H; Aridome, K; Hokita, S; Aikou, T
      Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer

      CANCER LETTERS
    98. Scanlan, MJ; Altorki, NK; Gure, AO; Williamson, B; Jungbluth, A; Chen, YT; Old, LJ
      Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9

      CANCER LETTERS
    99. Greiner, J; Ringhoffer, M; Simikopinko, O; Szmaragowska, A; Huebsch, S; Maurer, U; Bergmann, L; Schmitt, M
      Simultaneous expression of different immunogenic antigens in acute myeloidleukemia

      EXPERIMENTAL HEMATOLOGY
    100. Shintaku, I; Kawagoe, N; Yutani, S; Hoshi, S; Orikasa, S; Yoshizumi, O; Itoh, K
      Expression of the SART1 tumor rejection antigen in renal cell carcinoma

      UROLOGICAL RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 10:19:26